| A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 746 | 2016 |
| Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice B Abel, N Thieblemont, VJF Quesniaux, N Brown, J Mpagi, K Miyake, ... The Journal of Immunology 169 (6), 3155-3162, 2002 | 501 | 2002 |
| Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns BMN Kagina, B Abel, TJ Scriba, EJ Hughes, A Keyser, A Soares, ... American journal of respiratory and critical care medicine 182 (8), 1073-1079, 2010 | 498 | 2010 |
| Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk L Tortola, E Rosenwald, B Abel, H Blumberg, M Schäfer, AJ Coyle, ... The Journal of clinical investigation 122 (11), 3965-3976, 2012 | 428 | 2012 |
| Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection M Kopf, B Abel, A Gallimore, M Carroll, MF Bachmann Nature medicine 8 (4), 373-378, 2002 | 367 | 2002 |
| The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults B Abel, M Tameris, N Mansoor, S Gelderbloem, J Hughes, D Abrahams, ... American journal of respiratory and critical care medicine 181 (12), 1407-1417, 2010 | 317 | 2010 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 256 | 2018 |
| SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... The Journal of clinical investigation 131 (5), 2021 | 231 | 2021 |
| Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation A Soares, L Govender, J Hughes, W Mavakla, M de Kock, C Barnard, ... Journal of immunological methods 362 (1-2), 43-50, 2010 | 208 | 2010 |
| Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response BMN Kagina, B Abel, M Bowmaker, TJ Scriba, S Gelderbloem, E Smit, ... Vaccine 27 (40), 5488-5495, 2009 | 145 | 2009 |
| Metabolite changes in blood predict the onset of tuberculosis J Weiner 3rd, J Maertzdorf, JS Sutherland, FJ Duffy, E Thompson, ... Nature communications 9 (1), 5208, 2018 | 135 | 2018 |
| HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine N Mansoor, TJ Scriba, M de Kock, M Tameris, B Abel, A Keyser, F Little, ... The Journal of infectious diseases 199 (7), 982-990, 2009 | 121 | 2009 |
| Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8+ T-Cell Epitopes Identified in COVID-19 Convalescent Individuals AD Redd, A Nardin, H Kared, EM Bloch, B Abel, A Pekosz, ... Mbio 13 (2), e03617-21, 2022 | 101 | 2022 |
| CD8+ T-cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants AD Redd, A Nardin, H Kared, EM Bloch, A Pekosz, O Laeyendecker, ... Open Forum Infectious Diseases 8 (7), ofab143, 2021 | 101 | 2021 |
| Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease L Govender, B Abel, EJ Hughes, TJ Scriba, BMN Kagina, M De Kock, ... Vaccine 29 (1), 51-57, 2010 | 88 | 2010 |
| Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity JS Sutherland, AG Loxton, MC Haks, D Kassa, L Ambrose, JS Lee, L Ran, ... Clinical microbiology and infection 20 (4), O230-O238, 2014 | 85 | 2014 |
| Innate signals compensate for the absence of PKC-θ during in vivo CD8+ T cell effector and memory responses BJ Marsland, C Nembrini, N Schmitz, B Abel, S Krautwald, MF Bachmann, ... Proceedings of the National Academy of Sciences 102 (40), 14374-14379, 2005 | 85 | 2005 |
| Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study A Penn-Nicholson, T Hraha, EG Thompson, D Sterling, SK Mbandi, ... PLoS medicine 16 (4), e1002781, 2019 | 83 | 2019 |
| Hallmarks of improved immunological responses in the vaccination of more physically active elderly females. G Choon Lim Wong, V Narang, Y Lu, X Camous, MSZ Nyunt, C Carre, ... Exercise immunology review 25, 2019 | 78 | 2019 |
| Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells C Nembrini, B Abel, M Kopf, BJ Marsland The Journal of Immunology 176 (12), 7180-7188, 2006 | 71 | 2006 |
Willem HanekomAfrica Health Research InstituteVerified email at ahri.org
